Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF: Safety Overview

Metric BELANTAMAB MAFODOTIN BELANTAMAB MAFODOTIN-BLMF
Total FAERS Reports 2,293 150
Deaths Reported 843 60
Death Rate 36.8% 40.0%
Hospitalizations 599 36
Average Patient Age 67.3 yrs 65.9 yrs
% Female Patients 39.2% 48.3%
Manufacturer GlaxoSmithKline LLC N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription